Recent Headlines
Within Pharmaceuticals
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
Hula Health Making "Waves" in Health and Nutrition
Health Supplement Company Announces Launch. - January 13, 2016 - Hula Health
Novant Health to Detail Pharmacist-Driven Post-Discharge Drug Therapy Management Effort for High-Risk Patients in February 3, 2016 Webinar
A February 3, 2016 webinar will explore Novant Health's clinical pharmacist-driven medication management effort that identifies patients at high risk for readmissions or ED visits related to adverse drug events. - January 13, 2016 - Healthcare Intelligence Network
DelveInsight's Market Research Reports, 2016
DelveInsight has established its strong presence in therapeutic areas and has launched Analytical Reports on indication, mechanism of actions, drugs, Global API Manufacturers and specialized Reports on Gene Therapy, Anticoagulants, PD-1 and PDL-1, CART and Antibody Drug conjugates. After... - January 13, 2016 - DelveInsight
World Parkinson’s Program Strives to Improve Parkinson’s Care Around the Globe
World Parkinson's Program held its annual seminar in Toronto, Canada. The seminar was attended by both patients and healthcare professionals to discuss the situation faced by Parkinson's patients around the world. The focus was on patients in underdeveloped countries who cannot afford medications, walkers or canes. - January 12, 2016 - World Parkinson's Program
BÜHLMANN Laboratories Opens North American Affiliate
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - January 11, 2016 - BUHLMANN Diagnostics Corp
LSBU Accredits First Online Postgraduate Qualifications in Obesity Care and Management
London South Bank University (LSBU) has accredited three innovative new online courses in Obesity Care and Management, including the UK’s first completely online Masters degree in the field. The courses are being delivered by the College of Contemporary Health (CCH), which has been pioneering... - January 11, 2016 - College of Contemporary Health
Parkinson’s Patients in India Need More Resources, World Parkinson’s Program Emphasizes
A Canadian based non-profit organization, World Parkinson’s Program, held a seminar in Delhi, India to lecture about Parkinson’s disease. The lectures included multiple topics, and included a question and answer period. Those who attended included physicians, neurologists and other healthcare professionals from India. - January 10, 2016 - World Parkinson's Program
NanoHybrids Receives Grant Funding to Develop Breakthrough Technology in Cancer Detection and Diagnosis
NanoHybrids receives $225,000 from the National Cancer Institute (NCI) to develop breakthrough immunohistochemistry (IHC) technology. - January 10, 2016 - NanoHybrids
Largest U.S. Sponsor of Medicare ACOs to Share Data Analytics Tactics for Accountable Care During January 27, 2016 Webinar
Collaborative Health Systems, the nation's largest sponsor of Medicare Shared Savings ACOs, will share how data analytics has improved accountable care results during a January 27, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 07, 2016 - Healthcare Intelligence Network
Rx Partnership Receives $10,000 Critical Community Needs Grant from Dominion to Support Medication Access at Northern Neck Free Health Clinic
Grant will be used to provide the equivalent of $14.3M in prescription medications. - January 07, 2016 - Rx Partnership
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
SAPA and Beijing CFDA Delegation Held Workshop Successfully on Regulatory Landscape in China and US
On December 21, 2015, Sino-American Pharmaceutical Professionals Association (SAPA) hosted an 18-person delegation from Beijing Food and Drug Administration (Beijing CFDA) at the New Jersey Commercialization Center for Innovative Technology, located in North Brunswick, NJ. - January 06, 2016 - Sino-American Pharmaceutical Professionals Association
New Supplement Company Focuses on Successful Middle-Aged Men
A new supplement company called Silver Wolf Nutrition is being launched in 2016 to provide successful, middle-aged men with specific solutions to help them increase their longevity. The company did extensive research to produce a line of supplements that solve the specific issues that educated men aged 35 to 55 years old face on a regular basis. This includes natural remedies for enhanced workout energy, focus, sleep, muscle development and retention, and more. - January 06, 2016 - Silver Wolf Nutrition
Rx Partnership Awarded Grant from the Mary Washington Hospital to Support Medication Access at Lloyd F. Moss Free Clinic
The clinic has accessed more than $23.9 million worth of free medication and assisted over 6,200 patients with the help of nonprofit Rx Partnership and the financial support of the Mary Washington Hospital and other funders. - January 06, 2016 - Rx Partnership
January 26 Webinar to Examine Physician Reimbursement in 2016: Workflow Optimization for Chronic Care Management and Advance Care Planning
Bon Secours Medical Group will describe its approach to chronic care management reimbursement and positioning for billable advance care planning in 2016 during a January 26, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 05, 2016 - Healthcare Intelligence Network
Negotiations Are Finished. EU General Data Protection Regulation is Coming. Prepare Yourself Now.
After four years of intense wrangling for a uniform level of data protection in Europe, binding for each Member State, the chief negotiators of the European Parliament, the EU Commission, and the Council of Ministers came to an agreement on 12/15/2015 on the exact wording of the EU General Data Protection Regulation. The law firm of Kazemi & Lennartz Rechtsanwälte PartG is offering a range of training opportunities to companies already dealing with the new regulations at this time. - January 03, 2016 - Kazemi & Lennartz Rechtsanwälte PartG
Speaking of NEC Podcast Featuring Dr. Sergio Golombek Recently Launches
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - January 01, 2016 - The Morgan Leary Vaughan Fund, Inc.
H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors
H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.
Arlington Free Clinic Hosts Senator Adam Ebbin and Rx Partnership Board of Directors
State Senator Adam Ebbin (D-30th) and Rx Partnership’s Board of Directors toured the Arlington Free Clinic (AFC) on December 4 during the board’s quarterly meeting. Senator Ebbin and board members were able to learn about the clinic’s daily operations, challenges the clinic faces... - December 30, 2015 - Rx Partnership
RFID and Enhanced UDI Tracking Updates Announced by Matrix IT, Medical Tracking Systems
Matrix IT, Medical Tracking Systems has announced the addition of RFID data capture and product enhancements to TRACTUS, the world's first sterile field UDI scanning and compliance platform. The platform now also integrates with any health or inventory management system in a hospital. - December 30, 2015 - Matrix Medical Tracking Systems
World Parkinson’s Program Provides Quad Canes and Educational Material to Support Parkinson’s Patients in Kenya
World Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise. - December 19, 2015 - World Parkinson's Program
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
2016 Healthcare Trends: Population Health Prevails in Pay-for-Value Realm
Population health management remains the most influential factor in healthcare business operations for the second consecutive year, according to a complimentary trends snapshot by the Healthcare Intelligence Network (HIN). - December 15, 2015 - Healthcare Intelligence Network
Hemophilia Treatment ACE910 Bypasses Factor VIII Inhibitor in Affinity Biologicals Plasmas
Chugai Pharmaceutical's newly developed antibody ACE910 is a potential lifesaving treatment for Hemophilia A patients who have developed Factor VIII inhibitors. A first-in-human study (1) recently published by the American Society of Hematology indicates that ACE910 may be a safe and effective treatment for hemophilia A patients. - December 11, 2015 - Affinity Biologicals
Research Square Announces Video Summaries Solution to Help Researchers Communicate Their Work More Effectively
Research Square is partnering with MyScienceWork to offer engaging Video Summaries of research through the Polaris platform for universities and institutions. - December 11, 2015 - Research Square
World Parkinson’s Program Refugees Initiative
World Parkinson’s Program announces the launch of a series of educational campaigns for raising awareness of Parkinson’s disease and dementia in Syrian refugees arriving to Canada. “In the special Syrian refugee clinics set up by Canadian physicians, World Parkinson’s... - December 10, 2015 - World Parkinson's Program
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Therapeutics
ImaBiotech’s Multimaging™ Technology Chosen by Dermira for Its Skin Disposition Study
ImaBiotech today announced that Dermira, Inc., a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, chose ImaBiotech’s Multimaging technology for a skin disposition study in Yorkshire pigs. Dermira presented the... - December 07, 2015 - Imabiotech
Saint-Gobain Seals Installs New Automation Machine That Manufactures OmniSeal® Spring-Energized Seals
Saint-Gobain Seals installs new automation machine at Willich, Germany site, which forms and assembles OmniSeal® spring-energized seals. Adding this new equipment not only allows the business to assemble the product in large quantities but also maintain their high standard of world class manufacturing and quality. - December 04, 2015 - Saint-Gobain Performance Plastics, Seals Group
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
Detectamet Tags Protect Critical Data from Shock Destruction
How do you identify and trace food batches passing through your process? Detectamet detectable processing ID tags reduce the risk of lost data. They will survive high/low temperature parameters and ensure ID traceability and data correlation. They reduce the risk of food product contamination because they are metal detectable. - December 03, 2015 - Detectamet
IQ4I Research & Consultancy Published a New Report on “Neuromodulation Devices Global Market": Estimated to be Worth $9.3 Billion by 2021
Neuromodulation device market represents therapies specifically designed to deliver electrical current through internally implanted or externally stimulating devices to bring about desired change in nervous system. - December 03, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme
F2G Ltd, a UK based antifungal drug discovery and development company, today announced that its novel systemic antifungal product F901318 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways pilot programme. Initiated in March 2014, the Adaptive... - December 03, 2015 - F2G Ltd
Global IoT Security Market is Expected to Reach USD 464 Million in 2020
IoT Security Market for Utilities, Automotive, Healthcare and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2020. - December 01, 2015 - Market Research Store
Product Spotlight: Introducing Factor V Coagulation Antibodies from Affinity Biologicals Inc.
The human heart is an amazing vessel that pumps blood throughout the body, but sometimes genetic mutations make it difficult for the cardiovascular system to function the way it should. Most people inherit the factor V protein gene, which promotes healthy blood clotting throughout the body. Unfortunately, some inherit the factor V Leiden gene, which does just the opposite and prevents blood from clotting normally. - November 30, 2015 - Affinity Biologicals
Sydney Company Wins State Funding to Make HIV Self Test
Atomo Diagnostics awarded A$1.8 mil from the NSW Medical Device Fund to develop innovative HIV self test in Australia. - November 28, 2015 - Atomo Diagnostics
Best Practices for Antibiotic Use
Antibiotic resistance is one of the largest health issues facing the world in the next few years. Earlier this month, the World Health Organization held Global Antibiotic Awareness Week. Aceso Care worked to translate content released by the World Health Organization into Urdu to spread awareness... - November 28, 2015 - Aceso Care
Dr. Sebag Brings the Floaters Discussion to Paris; Dr. Sebag Presents VMR's Floater Program Findings to the French Ophthalmology Society’s Annual Meeting in Paris, France
Dr. Sebag presented VMR's floater program findings at the French Ophthalmology Society’s annual meeting in Paris. He described curing floaters with a limited vitrectomy where only the offending vitreous tissue opacities are removed, as opposed to the entire vitreous. This outpatient operation is performed in just 10 minutes, without sutures, under local anesthesia. The effectiveness of this surgery has been published in worldwide and patients are increasingly requesting the treatment. - November 26, 2015 - VMR Institute
How California Became the Center of the Stem Cell Universe - And Why That Matters to You
When Don Reed's son Roman was paralyzed in a college football game, the two began a 21 year quest for cure-- not just for paralysis, but for all forms of "incurable" disease. Joining with Bob Klein, father of a diabetic son, the Reeds helped pass Proposition 71, the California Stem Cells for Research and Cures Act. What happened next was a quiet triumph, step-by-step progress toward the cure of diseases which have plagued mankind for millennia. - November 25, 2015 - Americans for Cures Foundation
IQ4I Research & Consultancy Published a New Report on “Active Pharmaceutical Ingredients Global Market": Estimated to be Worth $173.5 Billion by 2020
The global Active Pharmaceutical Ingredients market is expected to reach $173.5 billion by 2020. This report analyzes the API market in terms of market revenue ($ Billion) for all segments, analysis is performed by synthesis type (Synthetic Chemicals API, Biotech API, HPAPI), Business type (Captive and Merchant) and therapeutic applications. - November 25, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Bioo Scientific Launches Completely Gel-Free or Low Input Small RNA Library Prep Kit
Bioo Scientific recently launched the NEXTflex™ Small RNA-Seq Kit v3, which improves small RNA analysis by making the library prep protocol completely gel-free or allowing for low-input small RNA library preparation. This kit also reduces the biases associated with small RNA sequencing by... - November 25, 2015 - Bioo Scientific
The MaxSignal Colistin ELISA Test Kit Can Help Prevent the Antibiotic Apocalypse by Keeping Last Resort Drugs Out of the Food Supply
Colistin resistance likely emerged after the drug was overused in farm animals. Colistin is intended to be used by physicians as a drug of last resort to treat Gram-negative superbug infections, but has been overused in agriculture. Bioo Scientific’s MaxSignal® Colistin ELISA Test Kit is the only commercially available ELISA optimized for the screening of colistin in poultry and other meat samples and eggs, to prevent the spread of colistin resistance by keeping colistin out of the food supply. - November 25, 2015 - Bioo Scientific
ASSIST Wins Big at IDTechEx Wearable USA 2015
With a vision to achieve a comprehensive assessment of health and environment through wearable technologies that enable multi-modal sensing, the ASSIST Center excels at making hassle-free and reliable nano-enabled devices for on body sensing. At the most recent IDTechEx Wearable USA conference the ASSIST Center and Dr. Zhu captivated judges winning an award: Best Wearable Material/Component Development. - November 25, 2015 - ASSIST Research Center
Aurora Scientific Inc. Unveils New Brand and Celebrates the Official Opening of a New Manufacturing Facility
On October 8, 2015, Aurora Scientific, a science and technology firm in Aurora, ON welcomed guests to celebrate the official launch of their new brand and grand opening of their new manufacturing facility. The event brought together local suppliers and dignitaries, valued clients, families and friends, marking a milestone for the growing company. - November 21, 2015 - Aurora Scientific Inc.
Altogen Biosystems In Vivo Pancreas Kit Has Applications for Diabetes Mellitus and Pancreatic Cancer
As featured by Science magazine, Altogen Biosystems offers a popular line of in vivo transfection reagent kits that include polymer, liposome, nanoparticle and PEG-liposome-based in vivo transfection kits as well as in vivo kits dedicated to targeting tissues, one of which is highlighted here: the... - November 21, 2015 - Altogen Biosystems
Noninvasix Among Finalists in 2015 HITLAB World Cup℠ International Healthcare Competition
Of the more than 192 international teams that submitted innovative healthcare solutions, five companies, including Noninvasix, Inc., will compete for $18,000 in total prize money at the HITLAB World Cup℠ finals held at Columbia University in New York City, December 4. Organized by New York... - November 21, 2015 - Noninvasix